financetom
Business
financetom
/
Business
/
Goldman, Morgan Stanley win dismissal of lawsuits over Archegos collapse
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Goldman, Morgan Stanley win dismissal of lawsuits over Archegos collapse
Mar 28, 2024 5:57 PM

NEW YORK (Reuters) - A U.S. judge on Thursday dismissed seven lawsuits by investors who accused Goldman Sachs Group Inc and Morgan Stanley of misconduct that fueled the rapid March 2021 collapse of Bill Hwang's $36 billion firm Archegos Capital Management.

U.S. District Judge Jed Rakoff in Manhattan dismissed the investors' market manipulation and insider trading claims with prejudice, meaning they cannot be brought again.

A different judge had dismissed the lawsuits last March, but let the investors sue Goldman and Morgan Stanley again. The Wall Street banks had been two of Archegos' prime brokers.

Archegos' collapse stemmed from Hwang's use of financial contracts known as total return swaps to take outsized stakes in his favorite holdings including ViacomCBS, Discovery and Baidu, building an estimated $160 billion of stock exposure.

Investors in Hwang's stocks sought to hold Goldman and Morgan Stanley liable for selling those stocks, based on their inside knowledge that Hwang would also be a seller because he was unable to meet margin calls.

The investors said the combined selling saddled them with huge losses, while Goldman and Morgan Stanley escaped billions of dollars of losses of their own.

In a one-paragraph order, Rakoff did not explain his reasoning and said an opinion would follow in due course.

Lawyers representing the investors did not immediately respond to requests for comment. Goldman did not immediately respond to similar requests. Morgan Stanley declined to comment.

Archegos' collapse caused billions of dollars in losses for banks such as Credit Suisse, which was later bought by Swiss rival UBS, and Japan's Nomura Holdings.

Hwang and former Archegos Chief Financial Officer Patrick Halligan face a scheduled May 8 criminal trial in Manhattan over their roles in the collapse.

Both pleaded not guilty to securities fraud, wire fraud and racketeering conspiracy charges. Hwang has also pleaded not guilty to separate market manipulation charges. The trial could last months.

The investor lawsuits in the U.S. District Court, Southern District of New York are Tan v. Goldman Sachs Group Inc et al, No. 21-08413; Florio v. Goldman Sachs Group Inc et al, No. 21-08618; Merson v. Goldman Sachs Group Inc et al, No. 21-08752; Ulanch v. Goldman Sachs Group Inc et al, No. 21-08897; Felix v. Goldman Sachs Group Inc et al, No. 21-10286; Scully v. Goldman Sachs Group Inc et al, No. 21-10791, and Lee v. Goldman Sachs Group Inc et al, No. 22-00169.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
MARA to Offer $700M Convertible Senior Note, Shares Fall 5%
MARA to Offer $700M Convertible Senior Note, Shares Fall 5%
Nov 19, 2024
MARA holdings announce a private offering of $700 million in convertible senior notes due 2030.MARA intends to use up to $200 million of the proceeds to repurchase a portion of its outstanding 2026 convertible notes.The offering includes an option for purchasers to acquire an additional $105 million in notes.MARA Holdings ( MARA ) announced a private offering of $700 million...
Viaro CEO accused in UK lawsuit of forging documents to steal millions
Viaro CEO accused in UK lawsuit of forging documents to steal millions
Nov 19, 2024
Nov 18 (Reuters) - The CEO of an independent British oil producer which is buying North Sea assets owned by Shell and Exxon Mobil ( XOM ) is being sued by his former employer for allegedly forging documents to steal substantial sums. Viaro Energy CEO Francesco Mazzagatti is accused by Singapore-based company Alliance Petrochemical Investment of being involved in the...
Market Chatter: Eli Lilly, Novo Nordisk Obesity Drugs Covered Mostly by Medicaid, Analysts Say
Market Chatter: Eli Lilly, Novo Nordisk Obesity Drugs Covered Mostly by Medicaid, Analysts Say
Nov 19, 2024
08:30 AM EST, 11/18/2024 (MT Newswires) -- Eli Lilly's ( LLY ) Zepbound and Novo Nordisk's ( NVO ) Wegovy are mostly covered by US government health plans than by commercial ones, Reuters reported Monday, citing an analysis by the Leverage consulting firm. Medicaid programs for low-income families are the single biggest source of coverage for new weight-loss drugs, giving...
NewGenIVF Locks In Long-Term Financing To Fuel Its Ambitions, Stock Jumps
NewGenIVF Locks In Long-Term Financing To Fuel Its Ambitions, Stock Jumps
Nov 19, 2024
NewGenIvf Group Limited ( NIVF ) shares are trading higher premarket on Monday after the company inked a binding term sheet with White Lion Capital for a $100 million equity line of credit, expandable to $500 million. As per the term sheet, NewGen can sell up to $100 million in common stock to White Lion over an initial 36-month period....
Copyright 2023-2026 - www.financetom.com All Rights Reserved